Munich, Germany – With the rise in gestational diabetes and metabolic disorders during pregnancy, metformin is also being prescribed more frequently. Although it is known that the oral antidiabetic agent can cross the placental barrier, the impacts on the brain development of the child are largely unknown. An interdisciplinary research...
treatment News
Hong Kong – For the first time, an AI-designed drug is in the second phase of clinical trials. Recently, the team behind the drug published a paper outlining how they developed it so fast. Made by Insilico Medicine, a biotechnology company based in New York and Hong Kong, the drug...
Stockholm, Sweden – Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals A pioneering study has demonstrated that semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality...
Kobe, Japan – Clarifying the cause of a skin disease led to the discovery of a new disease-causing gene, a new category of diseases, and new perspectives for both counseling and therapy. The Kobe University discovery is the first time that epigenetic silencing, the “switching off” of an otherwise intact...
New York, NY – A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debilitating symptoms in a multi-center clinical trial led by the Icahn School of Medicine at Mount...
Cleveland, Ohio – Researchers have presented the latest findings from a clinical trial aimed at discovering a cure for sickle cell disease, a painful genetic blood disorder with limited treatment options. Conducted as part of the multicenter RUBY Trial, researchers shared data on the safety and effectiveness of renizgamglogene autogedtemcel...
Cincinnati, Ohio – A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors. The team, led by UC’s Pankaj Desai, PhD, and Trisha Wise-Draper, MD, PhD, has...
Auckland, New Zealand – A molecule created at the University of Auckland is one step closer to becoming a treatment for an extremely rare and severely debilitating neurological disorder called Phelan-McDermid syndrome. According to Neuren Pharmaceuticals, a biopharmaceutical company that is listed on the Australian Securities Exchange, children with the...
The future treatment of Parkinson’s Disease has undergone tremendous development in recent years. Now, a breakthrough in research has emerged, delivering the strongest results for both side-effect-free and long-lasting treatment effects. Aarhus, Denmark – The results were just published in Nature Communications under the title “Enhanced production of mesencephalic...
Baton Rouge, Louisiana – A new partnership between a Pennington Biomedical physician-researcher at the Metamor Institute and an LSU School of Medicine oncologist has already saved women’s lives in southeast Louisiana. More than 60,000 women are diagnosed with endometrial cancer each year, a number that includes women much younger than...